The global market for Vascular Sealing Medical Glues was estimated at US$728.7 Million in 2024 and is projected to reach US$1.1 Billion by 2030, growing at a CAGR of 6.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Vascular Sealing Medical Glues market.
Global Vascular Sealing Medical Glues Market - Key Trends & Drivers Summarized
Why Are Surgeons and Hospitals Shifting Toward Vascular Sealing Medical Glues?
Over the past decade, vascular sealing medical glues have increasingly gained traction across surgical suites, emergency care units, and trauma centers worldwide. Their rapid adoption stems from the growing clinical emphasis on reducing operative time, minimizing complications such as hemorrhage, and improving post-operative recovery outcomes. With conventional suturing and stapling methods proving insufficient or cumbersome in certain vascular procedures especially in minimally invasive surgeries medical glues are being positioned as viable, efficient alternatives. These glues offer targeted hemostasis and seamless tissue approximation, particularly beneficial during cardiovascular and neurovascular interventions where precision and rapid response are critical. Furthermore, the evolution of biocompatible and bioresorbable glue formulations has alleviated earlier concerns related to immune response and tissue damage, thus boosting surgeon confidence and patient safety.How Are Regulatory Shifts and Biotech Innovation Reshaping the Competitive Landscape?
Global regulatory authorities such as the U.S. FDA and the European Medicines Agency have shown growing receptiveness to novel hemostatic agents, leading to a more streamlined approval process for vascular sealing glues. Simultaneously, investments in biomedical R&D have intensified, with both established med-tech giants and emerging biotech firms pouring resources into next-gen adhesive technologies. Innovations such as temperature-responsive glues, light-activated bonding agents, and synthetic mimics of naturally occurring fibrin and collagen have begun to redefine the product performance benchmarks. These scientific advancements not only offer stronger adhesion in high-pressure vascular environments but also support diverse anatomical applications. Patents and proprietary technologies now represent significant competitive differentiators, with market players racing to offer faster setting times, superior tensile strength, and improved bioabsorption profiles to gain regulatory and clinical acceptance.Are End-Use Shifts in Surgical Practice Driving Market Realignment?
Yes significant shifts in end-use preferences are causing a noticeable realignment in the vascular sealing glues market. The migration of complex surgical procedures to outpatient and ambulatory care centers fueled by the global movement toward cost-effective healthcare delivery has heightened the need for efficient, ready-to-use vascular sealing solutions. Concurrently, minimally invasive and robotic-assisted surgeries, which demand greater precision and minimal thermal damage to adjacent tissues, have pushed the demand for non-mechanical hemostatic methods. These shifts have also influenced procurement behaviors, with hospital networks and surgical facilities favoring glues that reduce operation time, eliminate the need for follow-up interventions, and integrate seamlessly with robotic surgical platforms. Furthermore, rising vascular surgery volumes, prompted by the aging global population and growing prevalence of lifestyle diseases like hypertension and diabetes, have broadened the addressable market for sealing agents across therapeutic areas including cardiology, oncology, and transplant surgery.What Forces Are Powering the Expansion of the Vascular Sealing Medical Glues Market?
The growth in the vascular sealing medical glues market is driven by several factors that span technology innovation, shifting end-use preferences, and evolving healthcare infrastructure. One of the primary catalysts is the development of advanced polymeric and bioinspired adhesives that offer superior adhesion even in dynamic, blood-rich environments a traditional challenge for older glue technologies. These innovations have strengthened the business case for integrating sealing glues in trauma surgery, cardiovascular procedures, and interventional radiology. Moreover, the increasing global penetration of minimally invasive surgery techniques has generated sustained demand for vascular glues, particularly in geographies where healthcare access is expanding. The rise of same-day discharge policies in surgical care is further amplifying interest in glues that reduce procedural time and post-op care. Also contributing to market momentum is the growing physician awareness and formal surgical training that includes exposure to vascular glue applications. On the systemic side, the proliferation of surgical infrastructure in emerging economies coupled with favorable reimbursement frameworks and the rise of public-private healthcare partnerships is opening up new adoption channels and expanding market accessibility. Together, these factors are not only sustaining but accelerating the global uptake of vascular sealing medical glues.Key Insights:
- Market Growth: Understand the significant growth trajectory of the Revascularization segment, which is expected to reach US$734.8 Million by 2030 with a CAGR of a 7.5%. The Other Procedures segment is also set to grow at 4.1% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $198.5 Million in 2024, and China, forecasted to grow at an impressive 10.3% CAGR to reach $220.1 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Vascular Sealing Medical Glues Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Vascular Sealing Medical Glues Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Vascular Sealing Medical Glues Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Abbott Laboratories, Adhex, Advanced Medical Solutions, Artivion, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 44 companies featured in this Vascular Sealing Medical Glues market report include:
- Abbott Laboratories
- Adhex
- Advanced Medical Solutions
- Artivion, Inc.
- Baxter International Inc.
- Becton, Dickinson and Company
- Chemence Medical
- CSL Behring
- CryoLife, Inc.
- Ethicon (Johnson & Johnson)
- H.B. Fuller Medical Adhesive Technologies
- Henkel AG & Co. KGaA
- Integra LifeSciences
- Medtronic plc
- Pfizer Inc.
- Stryker Corporation
- Success Bio-Tech Co., Ltd.
- Terumo Corporation
- Tissuemed Ltd.
- TISSIUM
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Adhex
- Advanced Medical Solutions
- Artivion, Inc.
- Baxter International Inc.
- Becton, Dickinson and Company
- Chemence Medical
- CSL Behring
- CryoLife, Inc.
- Ethicon (Johnson & Johnson)
- H.B. Fuller Medical Adhesive Technologies
- Henkel AG & Co. KGaA
- Integra LifeSciences
- Medtronic plc
- Pfizer Inc.
- Stryker Corporation
- Success Bio-Tech Co., Ltd.
- Terumo Corporation
- Tissuemed Ltd.
- TISSIUM
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 278 |
Published | June 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 728.7 Million |
Forecasted Market Value ( USD | $ 1100 Million |
Compound Annual Growth Rate | 6.4% |
Regions Covered | Global |